Statera Biopharma, Inc.

2022 Q3 Form 10-Q Financial Statement

#000143774922027371 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $506.1K $9.450M
YoY Change -94.64% 211.38%
Cash & Equivalents $500.0K $9.200M
Short-Term Investments $0.00 $233.6K
Other Short-Term Assets $248.5K $1.045M
YoY Change -76.23% 1805.38%
Inventory
Prepaid Expenses $97.52K $2.688M
Receivables $183.4K $144.2K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.214M $13.33M
YoY Change -90.9% 313.28%
LONG-TERM ASSETS
Property, Plant & Equipment $106.4K $119.1K
YoY Change -10.68% 1770.51%
Goodwill $9.267M $76.97M
YoY Change -87.96%
Intangibles $1.240M $1.575M
YoY Change -21.29%
Long-Term Investments
YoY Change
Other Assets $8.120K $5.008M
YoY Change -99.84%
Total Long-Term Assets $11.54M $84.71M
YoY Change -86.38% 1329904.93%
TOTAL ASSETS
Total Short-Term Assets $1.214M $13.33M
Total Long-Term Assets $11.54M $84.71M
Total Assets $12.75M $98.04M
YoY Change -87.0% 2933.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.132M $3.189M
YoY Change 155.01% 1036.57%
Accrued Expenses $6.634M $2.938M
YoY Change 125.78% 1463.93%
Deferred Revenue $386.9K $506.0K
YoY Change -23.54% 7314.39%
Short-Term Debt $6.396M $3.083M
YoY Change 107.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.23M $10.19M
YoY Change 118.22% 2005.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $12.92M
YoY Change -100.0%
Other Long-Term Liabilities $686.2K $737.5K
YoY Change -6.95%
Total Long-Term Liabilities $686.2K $13.65M
YoY Change -94.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.23M $10.19M
Total Long-Term Liabilities $686.2K $13.65M
Total Liabilities $22.92M $23.84M
YoY Change -3.88% 4827.21%
SHAREHOLDERS EQUITY
Retained Earnings -$144.1M -$52.30M
YoY Change 175.53% -68.94%
Common Stock $133.8M $126.4M
YoY Change 5.86% -24.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.24M $74.12M
YoY Change
Total Liabilities & Shareholders Equity $12.75M $98.04M
YoY Change -87.0% 2933.96%

Cashflow Statement

Concept 2022 Q3 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001318641
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
Statera Biopharma, Inc (fka Cytocom Inc)
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50744653
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50744653
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35484106
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35484106
stab Number Of Subsidiaries
NumberOfSubsidiaries
2 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32954
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0077155
dei Entity Address Address Line1
EntityAddressAddressLine1
4333 Corbett Drive, Suite 1082
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Collins
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80525
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
613-8802
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock, par value $0.005
dei Trading Symbol
TradingSymbol
STAB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54661890
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
506098 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
183383 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
216183 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1844732 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
97515 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
134603 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
981895 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
178048 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
132572 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
248457 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
837358 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1213501 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4147343 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
914226 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
964331 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5000000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
9267007 usd
CY2021Q4 us-gaap Goodwill
Goodwill
9267007 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1239853 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1580980 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106415 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
201901 usd
CY2022Q3 stab Assets Noncurrent Continuing Operations
AssetsNoncurrentContinuingOperations
11527501 usd
CY2021Q4 stab Assets Noncurrent Continuing Operations
AssetsNoncurrentContinuingOperations
17014219 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
8123 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
8123 usd
CY2022Q3 us-gaap Assets
Assets
12749125 usd
CY2021Q4 us-gaap Assets
Assets
21169685 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14442069 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5715956 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
323631 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
254998 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
386929 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
373468 usd
CY2022Q3 stab Stock Issuances Due Current
StockIssuancesDueCurrent
682078 usd
CY2021Q4 stab Stock Issuances Due Current
StockIssuancesDueCurrent
325828 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
6396486 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4575000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22231193 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11245250 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
686140 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
806140 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
10625000 usd
CY2022Q3 stab Liabilities Noncurrent Continuing Operation
LiabilitiesNoncurrentContinuingOperation
686140 usd
CY2021Q4 stab Liabilities Noncurrent Continuing Operation
LiabilitiesNoncurrentContinuingOperation
11431140 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
63 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
63 usd
CY2022Q3 us-gaap Liabilities
Liabilities
22917396 usd
CY2021Q4 us-gaap Liabilities
Liabilities
22676453 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
253724 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
177421 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
133526843 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
127743333 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
53695 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21169685 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6651 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144075557 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129482141 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-10241295 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1568038 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
73024 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
61270 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10168271 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1506768 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12749125 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
670473 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
236519 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2437139 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
236519 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
169354 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
115927 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
723961 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
115927 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
501119 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
120592 usd
us-gaap Gross Profit
GrossProfit
1713178 usd
us-gaap Gross Profit
GrossProfit
120592 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
230604 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3434977 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4446535 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6274936 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13350 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23242 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
69750 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26037 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1803607 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6306323 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8210391 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14981086 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2047561 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
9764542 usd
us-gaap Operating Expenses
OperatingExpenses
12726676 usd
us-gaap Operating Expenses
OperatingExpenses
21282059 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1546442 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9643950 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11013498 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21161467 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1810473 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3089301 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3593897 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3463572 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1810473 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3089301 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3593897 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3463572 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-0 usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-3356915 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-12733250 usd
us-gaap Profit Loss
ProfitLoss
-14607395 usd
us-gaap Profit Loss
ProfitLoss
-24625038 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8103 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13419 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13979 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50234111
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27036583
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45906659
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13419 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3348812 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12719831 usd
us-gaap Net Income Loss
NetIncomeLoss
-14593416 usd
us-gaap Net Income Loss
NetIncomeLoss
-24611619 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28671422
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-3356915 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-12733250 usd
us-gaap Profit Loss
ProfitLoss
-14607395 usd
us-gaap Profit Loss
ProfitLoss
-24625038 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
42217 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
86079 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3314698 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12733250 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-14521316 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-24625038 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5588 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-13419 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
11754 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-13419 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3320286 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12719831 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14533070 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24611619 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
143486122 usd
CY2021Q1 stab Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
0 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12723074 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-5286646 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
150922550 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
214 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6591723 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144331041 usd
CY2021Q3 stab Other Comprehensive Income Loss Merger And Recapitalization Adjustment Net Of Tax
OtherComprehensiveIncomeLossMergerAndRecapitalizationAdjustmentNetOfTax
-63046162 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
464703 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
234000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4957707 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-12733250 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
74208039 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1506768 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6456505 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
51308 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
452537 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-26087 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-7759933 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2435054 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1065684 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
69949 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-3490547 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
134022 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6921336 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
287637 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
355400 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
42217 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-3356915 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10168271 usd
us-gaap Profit Loss
ProfitLoss
-14607395 usd
us-gaap Profit Loss
ProfitLoss
-24625038 usd
us-gaap Depreciation
Depreciation
101940 usd
us-gaap Depreciation
Depreciation
8309 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
341127 usd
stab Noncash Equity Expense
NoncashEquityExpense
0 usd
stab Noncash Equity Expense
NoncashEquityExpense
235538 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
799858 usd
us-gaap Share Based Compensation
ShareBasedCompensation
-900784 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4957707 usd
stab Noncash Lease Expense Income
NoncashLeaseExpenseIncome
-1263 usd
stab Noncash Lease Expense Income
NoncashLeaseExpenseIncome
21472 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-588903 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
380615 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32800 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-63279 usd
stab Increase Decrease In Shortterm Investments
IncreaseDecreaseInShorttermInvestments
-134603 usd
stab Increase Decrease In Shortterm Investments
IncreaseDecreaseInShorttermInvestments
233642 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-884380 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2688472 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
45476 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-374626 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
13462 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-130829 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8726113 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
629994 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4731590 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20833791 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6454 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86057 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6454 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13559901 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6405195 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5685112 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
500000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14670740 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
200000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
-0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
329260 usd
stab Proceeds From Issuance Of Common Stock Due
ProceedsFromIssuanceOfCommonStockDue
711650 usd
stab Proceeds From Issuance Of Common Stock Due
ProceedsFromIssuanceOfCommonStockDue
769529 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-9303514 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-97737 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1686669 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20898384 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86079 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2014 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6338634 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13622480 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6844732 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
593869 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
506098 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14216349 usd
us-gaap Interest Paid Net
InterestPaidNet
539842 usd
us-gaap Interest Paid Net
InterestPaidNet
279329 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
210872 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144100000 usd
us-gaap Profit Loss
ProfitLoss
-14600000 usd
us-gaap Profit Loss
ProfitLoss
-24600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b><i>Use of Estimates</i></b></p> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1216149
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35011111
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4044004
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
331385 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
5000000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q3 stab Number Of Finitelived Intangible Assets
NumberOfFinitelivedIntangibleAssets
2 pure
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2021Q3 us-gaap Share Price
SharePrice
4.99
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8131585 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3964962 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2886575 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
195470 usd
CY2022Q3 stab Accrued Interest And Fees Current
AccruedInterestAndFeesCurrent
613056 usd
CY2021Q4 stab Accrued Interest And Fees Current
AccruedInterestAndFeesCurrent
51195 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2810853 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1504329 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14442069 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5715956 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
6396486 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4575000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
233120 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
10625000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1567 pure
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
119284 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
437749 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
264955 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
173644 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
182326 usd
CY2022Q3 stab Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
223605 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1401563 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
391792 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1009771 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
574247 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1239853 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1580980 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
341127 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
134022 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
45468
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1216149
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.24
stab Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriod
0
stab Sharebased Compensation Arrangements By Sharebased Payment Award Options Vested In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
27090
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
14.89
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1234527
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.44
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1234527
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1234527
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.44
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.44
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y10M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
stab Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
30777776
stab Class Of Warrant Or Right Issued During Period Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodWeightedAverageExercisePrice
0.46
stab Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
0
stab Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice
0
stab Class Of Warrant Or Right Forfeited And Cancelled During Period
ClassOfWarrantOrRightForfeitedAndCancelledDuringPeriod
-0
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2431168
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.48
stab Class Of Warrant Or Right Forfeited And Cancelled During Period Weighted Average Exercise Price
ClassOfWarrantOrRightForfeitedAndCancelledDuringPeriodWeightedAverageExercisePrice
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33208944
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.82

Files In Submission

Name View Source Status
0001437749-22-027371-index-headers.html Edgar Link pending
0001437749-22-027371-index.html Edgar Link pending
0001437749-22-027371.txt Edgar Link pending
0001437749-22-027371-xbrl.zip Edgar Link pending
cbli20220930_10q.htm Edgar Link pending
ex_438806.htm Edgar Link pending
ex_438807.htm Edgar Link pending
ex_438808.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
cbli20220930_10q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stab-20220930.xsd Edgar Link pending
stab-20220930_cal.xml Edgar Link unprocessable
stab-20220930_def.xml Edgar Link unprocessable
stab-20220930_lab.xml Edgar Link unprocessable
stab-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable